Imcheck Therapeutics
Immuno-modulatory antibodies
4
Funding Rounds
$277.9m
Money raised
Overview
Immuno-modulatory antibodies
-
Website:
- Business model: B2B
- Headquarters: Marseille
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ha** He**** Ch**** | - | - | |
| Pa** Fr**** | - | - | |
| Lo** Ma**** | - | - | |
| Cl**** Kn*** | - | - | |
| Pi**** d锟�**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Imcheck Therapeutics has raised a total of $277.85m in funding over 4 rounds.
Key Insights:
- Imcheck Therapeutics Series C round, June 2022: $103m
- ImCheck Therapeutics June 2022 Funding Round: $100m
- ImCheck Therapeutics Series B round, December 2019: $53m
- ImCheck Therapeutics Series A round, May 2017: $21.85m
Imcheck Therapeutics Series C round, June 2022
$103m
ImCheck Therapeutics June 2022 Funding Round
$100m
ImCheck Therapeutics Series B round, December 2019
$53m
ImCheck Therapeutics Series A round, May 2017
$21.85m
Industries
Imcheck Therapeutics is active in the following industries: